MCMedicalCodingSoftware
J0871

J0871: Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg

HCPCSActiveBETOS O1E

J0871 is a HCPCS Level II code for injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J0871

Long descriptor
Injection, daptomycin (endo), not therapeutically equivalent to j0878, 1 mg

The official wording. This is what the code means.

Short descriptor
Inj, daptomycin (endo) 1mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2026

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J0871

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J0871 is not quite right, the correct code is very often within a few positions of it.

  • J0801Injection, corticotropin (acthar gel), up to 40 units
  • J0802Injection, corticotropin (ani), up to 40 units
  • J0833Injection, cosyntropin, not otherwise specified, 0.25 mgterminated
  • J0834Injection, cosyntropin, 0.25 mg
  • J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
  • J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
  • J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
  • J0870Injection, imetelstat, 1 mg
  • J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
  • J0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
  • J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
  • J0875Injection, dalbavancin, 5 mg
  • J0877Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg
  • J0878Injection, daptomycin, 1 mg
  • J0879Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)
  • J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)
HCPCS Level II2026Q4-Oct· effective October 1, 2026